PRESS RELEASE published on 01/22/2024 at 09:00, 2 years 8 months ago GANÉ Aktiengesellschaft: Dr Uwe Rathausky and J. Henrik Muhle named Fund Manager of the Year 2024 GANÉ Aktiengesellschaft's Directors and Fund Advisors, Dr Uwe Rathausky and J. Henrik Muhle, have been honored with the 'Fund Manager of the Year 2024' award by Finanzen Verlag for their exceptional performance. The award recognizes their successful management of the GANÉ Global Equity Fund and ACATIS GANÉ Value Event Fund, underpinned by their unique value and event investment strategy. This achievement reflects their dedication to delivering excellent results for investors and their commitment to long-term success in the market. For more information, visit www.gane.de. GANÉ Aktiengesellschaft Dr Uwe Rathausky J. Henrik Muhle Fund Manager Of The Year Value Investment
PRESS RELEASE published on 01/22/2024 at 09:00, 2 years 8 months ago ANDRITZ holds Capital Markets Day on January 24 ANDRITZ, an international technology group, will hold its 2024 Capital Markets Day on January 24 in Leipzig, Germany. The event will provide updates on the group’s businesses, markets, strategy, and growth drivers, and will be available on the group’s website. ANDRITZ offers innovative solutions for various industries and end markets and aims to contribute to a sustainable future. With a global presence and a focus on long-term profitable growth, ANDRITZ is a market leader in Pulp & Paper, Metals, Hydropower, and Environment & Energy. Sustainable Solutions ANDRITZ Capital Markets Day Technology Group Business Strategy Global Market Leader
PRESS RELEASE published on 01/22/2024 at 08:30, 2 years 8 months ago Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months Abivax, a clinical-stage biotechnology company, provides its 2024 strategic outlook and key milestones, including the expected data read-outs and trial results for its lead drug candidate obefazimod in the treatment of ulcerative colitis and Crohn’s disease. The company also outlines its financial update and objectives for strengthening its product pipeline. Learn more about Abivax's priorities and milestones for 2024. Abivax Obefazimod Ulcerative Colitis Crohn’s Disease Clinical Trials
PRESS RELEASE published on 01/22/2024 at 08:30, 2 years 8 months ago Abivax: Perspectives stratégiques d’Abivax pour 2024 et principales étapes au cours des 12 prochains mois Abivax annonce ses perspectives stratégiques pour 2024 et les principales étapes des 12 prochains mois, y compris la publication des premiers résultats des essais d'induction du programme pivot ABTECT de phase 3 Abivax Obefazimod Stratégique Perspectives Étapes Clés
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 8 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announced the purchase of 105,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, as part of its share buyback program. The repurchased shares will be cancelled, and the company's total number of ordinary shares after settlement and cancellation will be 653,285,633. The detailed breakdown of individual trades made as part of the share buyback program is also provided in the announcement. London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 8 months ago Custodian Property Income REIT plc: Custodian Property Income REIT sells industrial unit at 9.5% premium to valuation Custodian Property Income REIT plc (CREI) announces the sale of an industrial unit in Milton Keynes at a 9.5% premium to valuation, representing a significant profit for shareholders. The sale proceeds will be used to reduce the company's existing debt facility and fund future portfolio improvements. Real Estate Investment Trust Custodian Property Income REIT Plc Industrial Unit Sale Premium To Valuation Portfolio Improvements
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 8 months ago Update on the Scheme and Resignation of Directors Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. Arix Bioscience PLC RTW Biotech Opportunities Ltd All-share Acquisition Resignation Of Directors Scheme Update
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 8 months ago Nordea Bank Abp: Repurchase of own shares on 19.01.2024 Nordea Bank Abp has completed the repurchase of its own shares on 19.01.2024 as part of a share buy-back program. The transactions were executed in public trading and in accordance with relevant regulations. After the disclosed transactions, Nordea holds treasury shares for capital optimisation and remuneration purposes. For further information, investors and media can contact the provided representatives. Investor Relations Treasury Shares Nordea Bank Abp Share Buy-back Program Stock Exchange
PRESS RELEASE published on 01/22/2024 at 07:34, 2 years 8 months ago Appointment of Vulcan Group Chief Financial Officer Vulcan Energy Resources Limited announces the appointment of Ms Felicity Gooding as the Group Chief Financial Officer, bringing over 20 years of extensive global CFO experience to the company. Her expertise in capital markets and project financing will be crucial in the financing of Vulcan's Zero Carbon Lithium™ Project. This strategic appointment reflects the company's growth and development stage. Additionally, Mr Robert Ierace will step down from his role as CFO-Australia. Vulcan Energy Resources Limited aims to decarbonize lithium production and contribute to the European EV supply chain with its Zero Carbon Lithium™ Project. CFO Appointment Vulcan Energy Resources Limited Felicity Gooding Zero Carbon Lithium™ Project European EV Supply Chain
PRESS RELEASE published on 01/22/2024 at 07:30, 2 years 8 months ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
Published on 09/29/2026 at 06:45, 9 minutes ago Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 2 hours 18 minutes ago The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 4 hours 24 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 6 hours 54 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 7 hours 54 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/29/2026 at 06:46, 8 minutes ago Julius Baer confirms conclusion of FINMA enforcement procedure in legacy matters
Published on 09/29/2026 at 06:12, 42 minutes ago EQS-Adhoc: Marley Spoon Group SE: Marley Spoon Group SE announces global workforce reductions
Published on 09/29/2026 at 05:35, 1 hour 19 minutes ago Castrol launches 'Castrol CORE', an integrated thermal management offer for data centres
Published on 09/28/2026 at 22:14, 8 hours 40 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 17:54, 12 hours 59 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 12 hours 59 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 13 hours 9 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 13 hours 19 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026